Mevion Medical registered for a $69 million initial public offering as it gears up to commercialize its proton therapy system.
Wall Street Beat
Kimberly-Clark readies Halyard Health medical device spinout
InVivo’s stock drops as ex-CEO dumps shares
As if InVivo Therapeutics (OTC:NVIV) wasn’t having a tough enough time already, the company’s stock is under even more pressure as former CEO Frank Reynolds has been liquidating his position over the last few weeks.
Feds charge ACT and ex-CEO for hiding stock sales
Medtronic shares hit 52-week high
Boston Scientific reassures on tax rate, J&J lawsuit over Guidant
BD: We’ll make half our products in Asia by 2024
Allergan caves to shareholder meeting after Valeant, Ackman rally support
Nanosphere might go up on the auction block
A year after closing on a $30 million offering, Nanosphere said yesterday that it’s hired an investment bank to examine the proverbial "strategic alternatives," including a possible sale of the molecular diagnostics technology business.